Lumen Bioscience: BARDA and Lumen Bioscience developing intranasal antibody treatment for COVID-19

As part of Biomedical Advanced Research and Development Authority's (BARDA) Beyond the Needle program, Lumen Bioscience is working to create a new antibody cocktail for treatment of SARS-CoV-2, delivered intranasally. Beyond the Needle, managed by the Division of Research Innovation ... Read More » The post BARDA and Lumen Bioscience developing intranasal antibody treatment for COVID-19 appeared first on Homeland Preparedness News.